
ExQor Advances Brain Therapy for Alzheimer’s Clinical Trials
ExQor Technologies, a biotech firm based in Boston, is moving into an important stage of its mission to fight Alzheimer’s disease with a new brain
ExQor Technologies, a biotech firm based in Boston, is moving into an important stage of its mission to fight Alzheimer’s disease with a new brain
H2 Medical Technologies, part of the H2 Global Group, has created the world’s first functional medical device using hydrogen designed for clinical trials focused on
Lumipulse pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp Labcorp, a global leader of innovative and comprehensive laboratory services, announced the availability of the
ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60